期刊文献+

个案管理与常规护理控制糖尿病患者心血管疾病危险因素的效果比较 被引量:44

暂未订购
导出
摘要 目的比较个案管理与常规护理控制糖尿病患者高血压、高血糖、高脂血症的效果。方法 556例血压(BP)>140/90 mmHg、糖化血红蛋白(HbA1C)>6.5%、低密度脂蛋白(LDL)>2.5 mmol/L的糖尿病患者分别接受个案管理(n=278)与常规护理(n=278)12个月,观察在1年中3项指标同时控制在BP<130/80 mmHg,HbA1C<6.1%,LDL<2.5 mmol/L的患者百分比。包括组成结果一中每一项指标的改善。结果个案管理组3项指标都达到控制水平的患者比例较高,个案管理组28.4%,常规护理组11.5%(P<0.01)。此外,个案管理组患者中除了LDL<2.5 mmol/L[个案管理组68例(57.6%),常规护理组82例(55.4%),P=0.61]未达到个体化治疗目标外,HbA1C<6.1%[个案管理组165例(73.7%),常规护理组121例(65.8%),P=0.04]、BP<130/80 mmHg[个案管理组59例(45.0%),常规护理组29例(25.4%),P<0.01]的患者比例都较常规护理组高。结论糖尿病患者进行12个月个案管理能有效改善多种心血管疾病危险因素的控制效果。
出处 《广东医学》 CAS CSCD 北大核心 2014年第2期328-330,共3页 Guangdong Medical Journal
基金 广东省医学科研基金立项项目(编号:A2012345)
  • 相关文献

参考文献9

  • 1YANG W Y, LU J M, WENG J P, et al. Prevalence of diabetes among men and women in China[ Jl. N Engl J Med, 2010, 362 (12), 1090 -1101.
  • 2白融.全面控制糖尿病患者的心血管疾病危险因素[J].临床内科杂志,2001,18(3):164-166. 被引量:3
  • 3张丽.健康教育对糖尿病患者的影响[J].山西医药杂志:下半月刊,2010,39(7):690-691.
  • 4王颖.糖尿病健康教育在自我管理中的应用[J].吉林医学,2010,31(35):6585-6586. 被引量:2
  • 5HEISLER M, VIJAN S, MAKKI F, et al. Diabetes control with re- ciprocal peer support versus nurse eare management: a randomi-zed tria[J]l. Ann Intern Med, 2010, 153(8) : 507 -515.
  • 6SOCHALSKI J, JAARSMA T, KRUMHOLZ HM, et al. What works in chronic care management : the case of heart failure [ J ]. Health Aft (Millwood) , 2009, 28( 1 ) : 179 - 189.
  • 7STONE RA, RAO RH, SEVICK MA, et al. Active care manage- ment supported by home telemonitoring in veterans with type 2 dia- betes : the DiaTel randomized controlled trial[ J 1. Diabetes Care, 2010, 33(3) : 478 -484.
  • 8CARTER B L, ROGERS M, DALY J, et al. The potency of team - based care interventions for hypertension : a meta- analysis [ J 1 ~ Areh Intern Med, 2009, 169 (19) : 1748 - 1755.
  • 9SHEA S, WEINSTOCK RS, TERESI JA, et al. A randomized tri- al comparing telemedicine case management with usual care in ol- der, ethnically diverse, medically under -served patients with dia- betes mellitus: 5 year results of the IDEATel study[ J]. J Am Med Inforn~ Assoc, 2009, 16(4) : 446 -456.

二级参考文献16

  • 1[1]Goldberg RB. Risk factor modification for cardiac disease: cardiovascular disease in iabetic patients. Med Clin North Am, 2000,84(1)∶81-93.
  • 2[2]Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA,1999, 281(14)∶1291-1297.
  • 3[3]Marks JB, Raskin P. Cardiovascular risk in diabetes: a brief review. J Diabetes Complications, 2000,14(2)∶108-115.
  • 4[4]Rodriguez BL, Lau N, Burchfiel CM,et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality.The Honolulu Heart Program. Diabetes Care,1999,22(8)∶1262-1265.
  • 5[5]United Kingdom Prospective Diabetes Study (UKPDS) Group(1998). Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet,1998, 352(9131)∶837-853.
  • 6[6]Pyorala K, Pedersen TR, Kjekslaus J,et al.Scandinavian Simvistatin Survival Study (4S) Group. Cholesterol lowering with simvistatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvistatin Survival Study (4S). Diabetes Care,1997,20(4)∶614-620.
  • 7[7]Goldberg RB, Mellies MJ, Sacks FM,et al.CARE Investigators (1998). Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation,1998,98(23)∶2513-2519.
  • 8[8]Curb JD, Pressel SL,Camel GL,et al.Systolic Hypertension in the Elderly Program Cooperative Research Group.Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA,1996, 276(23)∶1886-1892.
  • 9[9]Staessen JA, Thijs L, Gasowski J,et al. Systolic Hypertension in Europe(Syst-Eur) Trial Investigators.Treatment of isolated systolic hypertension in the elderly: further evidence from the Systolic Hypertension in Europe (Syst-Eur) Trial. Am J Cardiol,1998, 82(9B)∶20R-22R.
  • 10[10]The Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med, 2000,342(3)∶145-153.

共引文献3

同被引文献293

  • 1顾晓龙,邱健.《青年糖尿病患者的心血管疾病危险因素:AHA科学声明》解读[J].中国循环杂志,2015,30(S02):112-115. 被引量:1
  • 2彭贵海,陈玲玲,张雨馨,王治校,詹中群,王崇全,姚柏春.高血压后医院个性化护理服务模式[J].中国老年学杂志,2014,34(7):1947-1948. 被引量:20
  • 3李新辉,杜文娟,毛晓润,焦盼盼,陈瑞明.基于标准化护理语言的社区老年高血压患者家庭访视效果分析[J].中国全科医学,2013,16(27):3231-3233. 被引量:75
  • 4王晓丹,成守珍,龚凤球,张振路,谢凤兰,梁玲.应用心理动力护理理论有效实施心理护理[J].中国实用护理杂志,2007,23(6):69-70. 被引量:40
  • 5Carr DD. Case management for the subacute patient in askilled nursing facility[J]. Nurs Case Manag,2008,5(2) :83 - 92.
  • 6Case Management Society of America. Retrieved february[EB/ OL]. [2013 - 12 - 08]. http//www, cmsa. org/Home/CMSA/ Whatis. Case Manager/tabid/224/Default. aspx.
  • 7NCC. Nursing case management catalog[M]. Washington DC: ANCC,1998:3- 7.
  • 8Yarmolinsky J, Mueller N T, Duncan B B, et al. Coffee Con-sumption, Newly Diagnosed Diabetes, and Other Alterations in Glucose Homeostasis: A Cross - Sectional Analysis of the Longitudinal Study of Adult Health ( ELSA - Brasil) [ J ]. PLoS One, 2015, 10(5): 137.
  • 9Kaplon - Cieslicka A, Postula M, Rosiak M, et al. Associa- tion of adipokines and inflammatory markers with lipid control in type 2 diabetes[J]. Pol Arch Med Wewn, 2015, 15(18): 44.
  • 10Roger V L,Go A S, Lloyd Jones D M, et al. Heart disease and stroke statistics-2011 update from the American Heart Association[J].Circulation,2011,123(7):273 -275.

引证文献44

二级引证文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部